These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9484413)

  • 1. Quantification of brain metabolites in ALS by localized proton magnetic spectroscopy.
    Ikeda K; Iwasaki Y; Kinoshita M; Ichijo M; Fujii H; Matsuoka Y; Irimajiri S
    Neurology; 1998 Feb; 50(2):576-7. PubMed ID: 9484413
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy.
    Gredal O; Rosenbaum S; Topp S; Karlsborg M; Strange P; Werdelin L
    Neurology; 1997 Apr; 48(4):878-81. PubMed ID: 9109871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.
    Rule RR; Suhy J; Schuff N; Gelinas DF; Miller RG; Weiner MW
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):141-9. PubMed ID: 15512902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of creatine supplementation on metabolite levels in ALS motor cortices.
    Vielhaber S; Kaufmann J; Kanowski M; Sailer M; Feistner H; Tempelmann C; Elger CE; Heinze HJ; Kunz WS
    Exp Neurol; 2001 Dec; 172(2):377-82. PubMed ID: 11716561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS.
    Rooney WD; Miller RG; Gelinas D; Schuff N; Maudsley AA; Weiner MW
    Neurology; 1998 Jun; 50(6):1800-5. PubMed ID: 9633731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting neuronal dysfunction of hand motor cortex in ALS: A MRSI study.
    Wang Y; Li X; Chen W; Wang Z; Xu Y; Luo J; Lin H; Sun G
    Somatosens Mot Res; 2017 Mar; 34(1):15-20. PubMed ID: 28114839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain.
    Chan S; Shungu DC; Douglas-Akinwande A; Lange DJ; Rowland LP
    Radiology; 1999 Sep; 212(3):763-9. PubMed ID: 10478245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy.
    Kalra S; Cashman NR; Caramanos Z; Genge A; Arnold DL
    AJNR Am J Neuroradiol; 2003 Mar; 24(3):476-80. PubMed ID: 12637300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.
    Suhy J; Miller RG; Rule R; Schuff N; Licht J; Dronsky V; Gelinas D; Maudsley AA; Weiner MW
    Neurology; 2002 Mar; 58(5):773-9. PubMed ID: 11889242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis.
    Bradley WG; Bowen BC; Pattany PM; Rotta F
    J Neurol Sci; 1999 Oct; 169(1-2):84-6. PubMed ID: 10540013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ratio of N-acetyl aspartate to glutamate correlates with disease duration of amyotrophic lateral sclerosis.
    Sako W; Abe T; Izumi Y; Harada M; Kaji R
    J Clin Neurosci; 2016 May; 27():110-3. PubMed ID: 26765768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined use of conventional MRI and MR spectroscopic imaging increases the diagnostic accuracy in amyotrophic lateral sclerosis.
    Cervo A; Cocozza S; Saccà F; Giorgio SMDA; Morra VB; Tedeschi E; Marsili A; Vacca G; Palma V; Brunetti A; Quarantelli M
    Eur J Radiol; 2015 Jan; 84(1):151-157. PubMed ID: 25466774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALS surrogate markers. MRS.
    Kalra S; Arnold DL
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():111-4. PubMed ID: 15512889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings.
    Ellis CM; Simmons A; Andrews C; Dawson JM; Williams SC; Leigh PN
    Neurology; 1998 Oct; 51(4):1104-9. PubMed ID: 9781537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS.
    de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Ojeda I; Martínez A; Gil C; Arahuetes RM
    Environ Toxicol Pharmacol; 2013 Sep; 36(2):243-255. PubMed ID: 23688553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR spectroscopy evaluation and short-term outcome of olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients.
    Huang H; Tan K; Chen L; Xue Y; Wang H; Xi H; Liu Y; Zhang F; Zhang J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jan; 21(1):52-7. PubMed ID: 17305006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients.
    Pohl C; Block W; Träber F; Schmidt S; Pels H; Grothe C; Schild HH; Klockgether T
    J Neurol Sci; 2001 Sep; 190(1-2):21-7. PubMed ID: 11574102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis.
    Atassi N; Xu M; Triantafyllou C; Keil B; Lawson R; Cernasov P; Ratti E; Long CJ; Paganoni S; Murphy A; Salibi N; Seethamraju R; Rosen B; Ratai EM
    PLoS One; 2017; 12(5):e0177680. PubMed ID: 28498852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results.
    Kalra S; Genge A; Arnold DL
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):22-6. PubMed ID: 12745614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased motor cortex γ-aminobutyric acid in amyotrophic lateral sclerosis.
    Foerster BR; Callaghan BC; Petrou M; Edden RA; Chenevert TL; Feldman EL
    Neurology; 2012 May; 78(20):1596-600. PubMed ID: 22517106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.